-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JwFxrLQhCmQ+KPCwmbv7JXGheqFszNrdYfKlBTRkP0PEBOTrO2b/KyWlnB8LrCOG ZfPwxHDTB29YSHw9AFU8sw== 0001123274-11-000001.txt : 20110222 0001123274-11-000001.hdr.sgml : 20110221 20110222100852 ACCESSION NUMBER: 0001123274-11-000001 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110222 DATE AS OF CHANGE: 20110222 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-53711 FILM NUMBER: 11626864 BUSINESS ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PICTET & CIE EUROPE SA CENTRAL INDEX KEY: 0001123274 IRS NUMBER: 000000000 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1 BOULEVARD ROYAL STREET 2: LUXEMBOURG CITY: LUXEMBOURG L-2016 STATE: N4 ZIP: 999999999 BUSINESS PHONE: 467171 MAIL ADDRESS: STREET 1: 1 BOULEVARD ROYAL STREET 2: LUXEMBOURG CITY: LUXEMBOURG L-2016 STATE: N4 ZIP: 2016 FORMER COMPANY: FORMER CONFORMED NAME: PICKET & CIE EUROPE SA DATE OF NAME CHANGE: 20000905 SC 13G/A 1 medivation.txt MEDIVATION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Medivation Inc ------------------------- (Name of Issuer) COMMON STOCK -------------------------------- (Title of Class of Securities) 58501N101 ---------------- (CUSIP Number) February 2nd, 2010 --------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |X| Rule 13d-1(c) |_| Rule 13d-1(d) The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - - ------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON PICTET FUNDS - BIOTECH - - ------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |X| - - ------------------------------------------------------------------------- 3 SEC USE ONLY - - ------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Luxembourg - - ------------------------------------------------------------------------- 5 SOLE VOTING POWER 2'097'300 --------------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES BENEFICIALLY 0 OWNED BY --------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 0 WITH --------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 - - ------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2'097'300 - - ------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |_| - - ------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.07% - - ------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* INVESTMENT FUND - - ------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT Item 1. (a) Name of Issuer: Medivation Inc (b) Address of Issuer's Principal Executive Offices: 3rd Floor 201 Spear Street San Francisco, CA 94105 United States Item 2. (a) Name of Person Filing: PICTET FUNDS - BIOTECH (b) Address of Principal Business Office or, if none, Residence: Luxembourg (c) Citizenship: Luxembourg (d) Title of Class Securities: Common Stock (e) CUSIP Number: N.A. Item 3. Not applicable. Item 4. Ownership (a) Amount Beneficially Owned: 2'097'300 (b) Percent of Class: 6.07% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 2'097'300 (ii) shared power to vote or to direct the vote:0 (iii) sole power to dispose or to direct the disposition of: 0 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class Not applicable. Item 6. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not Applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of the Group Not applicable. Item 10. Certification By signing below I certify that, to the best if my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquire and to the best of my knowledge and belief, We certify that the information set forth in this statement is true, complete and correct. Date: February 15th, 2011 Charles Vallee Claudy Huart -------------- -------------- -------------- --------------- -----END PRIVACY-ENHANCED MESSAGE-----